Caraco Pharma gets FDA OK for generic Metaglip
Jan 14 (Reuters) - Generic drugmaker Caraco Pharmaceutical Laboratories Ltd (CPD.A: Quote, Profile, Research, Stock Buzz) said U.S. health regulators approved its generic version of Bristol-Myers Squibb's (BMY.N: Quote, Profile, Research, Stock Buzz) diabetes drug Metaglip.
The approval is for glipizide/metformin hydrochloride tablets, 2.5/250 mg, 2.5/500 mg and 5/500 mg, the company said in a statement.
For the 12 months ended September 2007, glipizide/metformin HCl generic and brand products combined had annual sales of about $25 million, according to health information provider IMS Data, the company said. (Reporting by Neetha Mahadevan in Bangalore)
© Thomson Reuters 2008 All rights reserved
Ads by Career Builder
Healthcare Recruiter/Entry-Level Sales Management
Details: Maxim Healthcare Services is one...leader in the healthcare industry through...industry. Maxim Healthcare Services is recognized...
Director of Development-Healthcare
Details: ...of Development-Healthcare Director of Development...of Development-Healthcare position, and have...background that includes:Healthcare, Director of Development...
Client Manager - CDG Healthcare & Institutions Banking - (Boston
Details: ...be part of a new group established exclusively to grow our healthcare and institutions banking business through marketing, sales...
Medical & Healthcare Opportunities
Details: ...in life. Medical / Healthcare Some of the opportunities...in the Medical and Healthcare area include: Dental...







